ACTIVITY OVERVIEW | This Webcast contains video and downloadable slides from the symposium Evaluating the Current Therapeutic Landscape for Advanced Prostate Cancer, a prIME Oncology educational activity that was held on 17 October 2011 during the 31st Congress of Société Internationale D’Urologie in Berlin, Germany. |
FACULTY | Chair
Cora Sternberg, MD, FACP
San Camillo Forlanini Hospital
Rome, Italy
Faculty
Karim Fizazi, MD, PhD
Institut Gustave Roussy
Villejuif, France
Peter Mulders, MD, PhD
University Medical Center Nijmegen
Nijmegen, the Netherlands
Thomas Powles, MD
St Bartholomew’s Hospital
London, United Kingdom
|
TARGET AUDIENCE | This educational activity is specifically designed for medical and surgical oncologists, urologists, radiologists, and other healthcare providers interested and/or involved in the treatment of patients with prostate cancer.The information in this activity is intended for healthcare professionals based outside of the United States. You will be asked to provide your credentials before accessing the activity. |
|
|
 |
|
Expert Discussion
|
 |
|
Downloadable Slides
|
|
 |
TOPICS | Examining the issues and unmet needs in the treatment of advanced prostate cancer
Cora Sternberg, MD, FACP
Integration of newly approved therapies into the continuum of care for advanced prostate cancer
Thomas Powles, MD
What are the promising novel strategies on the horizon in advanced prostate cancer?
Karim Fizazi, MD, PhD
Importance of the multidisciplinary team in prostate cancer: The urologist’s perspective
Peter Mulders, MD, PhD
|
LEARNING OBJECTIVES | After successful completion of this educational activity, participants should be able to:
- Identify areas of unmet need in the treatment of patients with advanced prostate cancer
- Evaluate newly approved therapies for the treatment of advanced prostate cancer, and evaluate how to effectively incorporate these agents into the standard of care
- Examine the rationale, efficacy, and safety of novel therapies under investigation for advanced prostate cancer, including emerging targeted therapies, immunotherapies, and chemotherapeutic agents
- Discuss the importance of multidisciplinary treatment strategies in the care of patients with advanced prostate cancer
|
|
|
|
Organizer | This Webcast is a prIME Oncology activity.
|
SUPPORT | Support for this educational activity has been provided by Dendreon Corporation.
|
|
